Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558804 · ClinicalTrials.gov registry record
GRoup A StrePtococcus
A clinical trial of Streptococcal Pharyngitis, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 180
- Enrollment target
- 1
- Study location
NCT01558804: Recruiting study of Streptococcal Pharyngitis, sponsored by University of Wisconsin, Madison.
NCT01558804 is a study of Streptococcal Pharyngitis that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 180 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01558804, a study of Streptococcal Pharyngitis, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to help understand why some children become carriers of strep and whether children who are carriers need to be treated with antibiotics.
Primary Outcome
The specific aim of this study is to identify 30 children with acute pharyngitis due to Group A streptococcus (GAS) and 30 children who are pharyngeal carriers of GAS. Thirty percent of children 4 to 16 years of age with acute pharyngitis occurring between October and May will have a positive culture or rapid antigen detection test for GAS. Approximately 10-15% of these children with pharyngitis and a positive culture or rapid antigen detection test (RADT) for GAS will be carriers
Conditions Studied
Interventions
- OTHER Identifying group A strep carriers
Study Locations (1)
Wisconsin
- UW Health Pediatric Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2011-05-09 |
| Est. Completion | 2028-06 |
What NCT01558804 shows while recruiting
NCT01558804 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Streptococcal Pharyngitis appearing as the primary indexed condition, and to 1 intervention - of which Identifying group A strep carriers is the first listed.
NCT01558804 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01558804 about?
NCT01558804 is a clinical study titled "GRoup A StrePtococcus". The purpose of the research is to help understand why some children become carriers of strep and whether children who are carriers need to be treated with antibiotics.
What is the current status of trial NCT01558804?
This trial is currently recruiting. The enrollment target is 180 participants. The study started on 2011-05-09. Estimated completion is 2028-06.
What conditions does trial NCT01558804 study?
This clinical trial studies the following conditions: Streptococcal Pharyngitis.
What interventions are being tested in trial NCT01558804?
The interventions under investigation include: Identifying group A strep carriers (OTHER).
Who is sponsoring clinical trial NCT01558804?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01558804 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
- NCT03610763 · 180 participants · NA
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI